Retinal Vessel Diameter

Ophthalmology

Volumn 113, Issue 5, 2006, Pages

  Kaushik, Shweta ^a   Wang, Jie Jin ^a   Mitchell, Paul ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

ANALYSIS OF COVARIANCE; BLOOD VESSEL DIAMETER; CALCULATION; CARDIOVASCULAR RISK; CLINICAL TRIAL; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; LETTER; LONG TERM CARE; MENOPAUSAL SYNDROME; PRIORITY JOURNAL; RETINA BLOOD VESSEL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STROKE; VASCULAR DISEASE; VISION;

EID: 33646130609     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2006.01.060     Document Type: Letter

References (5)

1. Wong T.Y., Knudtson M.D., Klein B.E., et al. Estrogen replacement therapy and retinal vascular caliber. Ophthalmology 112 (2005) 553-558
2. Leung H., Wang J.J., Rochtchina E., et al. Does hormone replacement therapy influence retinal microvascular caliber?. Microvasc Res 67 (2004) 48-54
3. Manson J.E., Hsia J., Johnson K.C., et al., Women's Health Initiative Investigators. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 349 (2003) 523-534
4. Wassertheil-Smoller S., Hendrix S.L., Limacher M., et al., WHI Investigators. Effect of estrogen plus progestin on stroke in postmenopausal women. The Women's Health Initiative. a randomized trial. JAMA 289 (2003) 2673-2684
5. Hulley S., Grady D., Bush T., et al., Heart and Estrogen/Progestin Replacement Study Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280 (1998) 605-613